Latest Working Capital News

Intelligent Monitoring Group Limited has significantly reduced its half-year loss while increasing revenue and adjusted EBITDA, driven by organic growth and key acquisitions in Australia and New Zealand.

LaserBond Ltd has reported a robust first half of FY26, with revenue up 13.4% and net profit after tax more than doubling, underpinned by a significant licensing agreement with Komatsu and ongoing R&D investments.

PWR Holdings Limited has reported a robust half-year performance with revenues climbing 27.8% and net profit rising 38.6%, underpinned by strategic expansion in motorsports and aerospace sectors. The company also announced a higher fully franked interim dividend of 3 cents per share.

MaxiPARTS Limited reported a modest 1.8% revenue increase to $139.3 million for the half-year ended December 2025, while net profit after tax dipped slightly by 2%. The company raised its interim dividend to 4.15 cents per share, reflecting confidence in its growth initiatives and cash flow outlook.

Terragen Holdings reports a 23% reduction in half-year net loss amid strategic shifts and completes a $7 million equity raise to accelerate global commercialisation of its biological agricultural products.

Horizon Minerals has successfully raised A$175 million through a two-tranche institutional placement, complemented by a planned A$10 million share purchase plan, to fund the development of its Black Swan Processing Hub near Kalgoorlie.

Medical Developments International (MVP) reported an 8% revenue increase driven by strong Penthrox growth, despite a slight EBIT loss impacted by foreign exchange. The company advances pediatric approvals and targets further volume gains.

NRW Holdings reported a robust first half of FY26, driven by strong segment performances and the strategic acquisition of Fredon Industries, boosting revenue and profits significantly.

PLS Group reported a robust first half of FY26, with lithium production up 6% and a 40% jump in realised prices driving a 47% revenue increase. Underlying EBITDA soared 241%, underscoring operational efficiency and cost discipline.

Bega Cheese Limited reported a strong half-year performance with a 5% revenue increase and a 55% jump in net profit, alongside a higher interim dividend and ongoing operational consolidation.

MEC Resources Ltd reported a half-year loss of $431,971 amid ongoing legal challenges over key gas exploration permits, while progressing investments in clean energy and neurotechnology. The company also completed a $359K options placement, reinforcing its financial position.

Paradigm Biopharmaceuticals has drawn down US$5 million from its Convertible Note Facility to fund the next phase of its global Phase 3 trial for knee osteoarthritis treatment, marking a key step as patient recruitment nears 50%.